Platform-based Mild Cognitive Impairment (MCI) Trial
Platform-Based Mild Cognitive Impairment (MCI) Trial to Address Maladaptive Behaviors
1 other identifier
interventional
38
1 country
1
Brief Summary
The process of receiving a diagnosis of mild cognitive impairment (MCI) is recognized to induce behavioral responses that can be either adaptive or maladaptive. Five specific areas of concern have been identified, including: 1) failure to plan for future decline, decreased compliance and interaction with medical care providers, 3) decreased confidence and reduced social engagement, 4) increased physical limitations and 5) decreased medication compliance. In this pilot study, participants with MCI and their study partners will participate in behavioral interventions (primarily training workshops and classes) targeting each of these five areas of potential maladaptive behaviors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2019
CompletedFirst Posted
Study publicly available on registry
June 17, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2021
CompletedFebruary 25, 2022
February 1, 2022
2.1 years
June 12, 2019
February 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-Efficacy; general self-efficacy scale (GSES)
The general self-efficacy scale (GSES) is a ten-item scale. Scores range from 10-40, with higher scores indicating more self-efficacy.
9 months
Secondary Outcomes (29)
Readiness to complete advance directives (ACPES)
9 months
Motivations Around Advance Care Planning (ADS)
9 months
Long Term Care Planning Behavior Scale (LTCP), planning subscale
9 months
Long-Term Supports and Services (LTSS)
9 months
World Health Organization Quality-of-Life (WHOQOL), Brief - Psychological and Social Relationship subscale
9 months
- +24 more secondary outcomes
Study Arms (1)
Patients with MCI
EXPERIMENTALParticipants diagnosed with mild cognitive impairment (MCI) and their study partners
Interventions
This intervention will include attending an advance directives meeting, a living arrangements workshop, and a psychosocial education training workshop.
This intervention includes creating a health portfolio, health record access training, and a medical engagement workshop
This intervention includes mindfulness training, a pre-experience training techniques workshop and a memory strategies class.
This intervention includes physical/occupational therapy (PT/OT), a home safety assessment, and an independent exercise program.
This intervention includes using automated pillboxes to ensure medication compliance, optimizing appropriate medication use through review, and engaging with memory medications via class.
Eligibility Criteria
You may qualify if:
- current subjects of the University of Kentucky Alzheimer's Disease Center (ADC)
- meet consensus guidelines for mild cognitive impairment (MCI) developed by the Second International Working Group on MCI
- have been diagnosed within the last year
- able to provide informed consent
- have a study partner willing to participate
You may not qualify if:
- history of stroke
- significant neurological or psychiatric conditions
- brain injury
- residence in institutional setting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allison Gibsonlead
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40536, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allison Gibson, PhD, MSW
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 12, 2019
First Posted
June 17, 2019
Study Start
November 1, 2019
Primary Completion
December 14, 2021
Study Completion
December 14, 2021
Last Updated
February 25, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share